These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25171932)

  • 41. Symmetric giant xanthogranulomas in Erdheim-Chester disease.
    Taguchi T; Sano S; Iwasaki Y; Terada Y
    Eur J Nucl Med Mol Imaging; 2009 Jul; 36(7):1198. PubMed ID: 19296104
    [No Abstract]   [Full Text] [Related]  

  • 42. Variability in the efficacy of the IL1 receptor antagonist anakinra for treating Erdheim-Chester disease.
    Cohen-Aubart F; Maksud P; Saadoun D; Drier A; Charlotte F; Cluzel P; Amoura Z; Haroche J
    Blood; 2016 Mar; 127(11):1509-12. PubMed ID: 26847247
    [No Abstract]   [Full Text] [Related]  

  • 43. Long-term follow-up of mTOR inhibition for Erdheim-Chester disease.
    Pegoraro F; Maniscalco V; Peyronel F; Westenend PJ; Hendriksz TR; Roperto RM; Palumbo AA; Sieni E; Romagnani P; van Bommel EFH; Vaglio A
    Blood; 2020 May; 135(22):1994-1997. PubMed ID: 32299103
    [No Abstract]   [Full Text] [Related]  

  • 44. Erdheim-Chester disease with rare radiological features in a 14-year old girl with pre-B Acute Lymphocytic Leukemia and Diabetes Mellitus.
    Krishna VV; James TE; Chang KT; Yen SS
    J Radiol Case Rep; 2014 Aug; 8(8):7-15. PubMed ID: 25426240
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Erdheim-Chester disease and concomitant tuberculosis successfully treated with chemotherapy and long-term steroids.
    Badzek S; Misir-Krpan A; Krajina Z; Radman I; Stern-Padovan R; Dotlić S
    Coll Antropol; 2007 Jun; 31(2):621-3. PubMed ID: 17847948
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Constrictive pericarditis in Erdheim-Chester disease: an integrated echocardiographic and magnetic resonance approach.
    Palazzuoli A; Mazzei MA; Ruocco G; Volterrani L
    Int J Cardiol; 2014 Jun; 174(2):e38-41. PubMed ID: 24768396
    [No Abstract]   [Full Text] [Related]  

  • 47. [Neurological onset of Erdheim-Chester disease].
    Cuello-Oderiz C; Pigretti S; Patrucco L
    Rev Neurol; 2014 Dec; 59(12):572-4. PubMed ID: 25501457
    [No Abstract]   [Full Text] [Related]  

  • 48. Erdheim-Chester Disease Presenting With Diplopia: A Challenging Diagnosis With Effective Treatment.
    Tavakoli M; Roghaee S; Gunturu M; Omuro AM; Lam BL; Mendoza-Santiesteban CE
    J Neuroophthalmol; 2021 Sep; 41(3):e324-e325. PubMed ID: 32956221
    [No Abstract]   [Full Text] [Related]  

  • 49. Suprasellar non-Langerhans cell histiocytosis (Erdheim-Chester disease)--a case report.
    Sharma M; Vettiyil B; Bartlett E; Yu E
    Clin Imaging; 2013; 37(2):354-7. PubMed ID: 23465991
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Scintigraphic diagnosis of Erdheim-Chester disease.
    Balink H; Hemmelder MH; de Graaf W; Grond J
    J Clin Oncol; 2011 Jun; 29(16):e470-2. PubMed ID: 21422416
    [No Abstract]   [Full Text] [Related]  

  • 51. Images in cardiovascular medicine. High resolution images obtained with ultrasound and magnetic resonance imaging of pericarotid fibrosis in Erdheim-Chester disease.
    Gauvrit JY; Oppenheim C; Girot M; Lambert M; Gautier C; Hatron PY; Pruvo JP; Leclerc X
    Circulation; 2004 Oct; 110(15):e443-4. PubMed ID: 15477423
    [No Abstract]   [Full Text] [Related]  

  • 52. Cardiac involvement in Erdheim-Chester disease: echocardiographic appearance and value of cardiac MRI.
    Merli E; Savelli F; Lovato L; Zompatori M
    Eur Heart J Cardiovasc Imaging; 2012 Feb; 13(2):198. PubMed ID: 22080452
    [No Abstract]   [Full Text] [Related]  

  • 53. Cardiovascular Manifestations of Erdheim-Chester's Disease: A Case Series.
    Costa IBSDS; Abdo ANR; Bittar CS; Fonseca SMR; Moraes ASHT; Kalil Filho R; Pereira J; Hajjar LA
    Arq Bras Cardiol; 2018 Dec; 111(6):852-855. PubMed ID: 30517380
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sarcoidosis occurring during BRAF/MEK inhibitors is associated with paradoxical ERK activation in Erdheim-Chester patients.
    Amoura A; Haroche J; Emile JF; Barete S; Helias-Rodzewicz Z; Charlotte F; Maisonobe T; Amoura Z; Cohen Aubart F
    J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):e348-e350. PubMed ID: 31002424
    [No Abstract]   [Full Text] [Related]  

  • 55. Efficacy of biological agents in the treatment of Erdheim-Chester disease.
    Goyal G; Shah MV; Call TG; Litzow MR; Wolanskyj-Spinner AP; Koster MJ; Tobin WO; Vassallo R; Ryu JH; Hook CC; Hogan WJ; Go RS
    Br J Haematol; 2018 Nov; 183(3):520-524. PubMed ID: 29082516
    [No Abstract]   [Full Text] [Related]  

  • 56. Erdheim-Chester Disease.
    Shah MV; Go RS
    Mayo Clin Proc; 2015 Sep; 90(9):1310. PubMed ID: 26355408
    [No Abstract]   [Full Text] [Related]  

  • 57. FDG PET/CT for biopsy guidance in Erdheim-Chester disease.
    Lin E
    Clin Nucl Med; 2007 Nov; 32(11):860-1. PubMed ID: 18075421
    [No Abstract]   [Full Text] [Related]  

  • 58. Anakinra-responsive lichen planus in a woman with Erdheim-Chester disease: a therapeutic enigma.
    Cohen PR; Kurzrock R
    Dermatol Online J; 2014 Jan; 20(1):21241. PubMed ID: 24456945
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Images in cardiovascular medicine. Cardiac involvement in Erdheim-Chester disease: magnetic resonance and computed tomographic scan imaging in a monocentric series of 37 patients.
    Haroche J; Cluzel P; Toledano D; Montalescot G; Touitou D; Grenier PA; Piette JC; Amoura Z
    Circulation; 2009 Jun; 119(25):e597-8. PubMed ID: 19564564
    [No Abstract]   [Full Text] [Related]  

  • 60. Interferon-alpha in cardiac Erdheim-Chester disease.
    Monti L; Haroche J; Sciarra A; Balzarini L; Fiamengo B; Amoura Z; Graziani G
    J Am Coll Cardiol; 2011 Dec; 58(25):2695. PubMed ID: 22152958
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.